Biotech startup expands from Cambridge to Watertown

Cambridge biotech startup Arkuda Therapeutics, which aims to tackle neurodegenerative diseases such as dementia, plans to relocate to Watertown’s Arsenal Yards mixed-use development early next year. The startup is expanding out of the Kendall Square incubator space of Atlas Venture, which invested $44 million in seed capital in Arkuda.